Results from Cardiovascular Outcome Trials in Diabetes

Endocrinol Nutr. 2016 Aug-Sep;63(7):317-9. doi: 10.1016/j.endonu.2016.04.001. Epub 2016 Jun 17.
[Article in English, Spanish]
No abstract available

MeSH terms

  • Benzhydryl Compounds / therapeutic use
  • Cardiovascular Diseases / epidemiology
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / prevention & control*
  • Clinical Trials as Topic*
  • Diabetes Complications / drug therapy*
  • Diabetes Mellitus, Type 2 / drug therapy
  • Dipeptidyl-Peptidase IV Inhibitors / therapeutic use
  • Glucagon-Like Peptide-1 Receptor / antagonists & inhibitors
  • Glucosides / therapeutic use
  • Hospitalization
  • Humans
  • Hypoglycemic Agents / pharmacology
  • Hypoglycemic Agents / therapeutic use*
  • Molecular Targeted Therapy
  • Sodium-Glucose Transporter 2
  • Sodium-Glucose Transporter 2 Inhibitors
  • Treatment Outcome

Substances

  • Benzhydryl Compounds
  • Dipeptidyl-Peptidase IV Inhibitors
  • Glucagon-Like Peptide-1 Receptor
  • Glucosides
  • Hypoglycemic Agents
  • SLC5A2 protein, human
  • Sodium-Glucose Transporter 2
  • Sodium-Glucose Transporter 2 Inhibitors
  • empagliflozin